BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8610439)

  • 1. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus.
    Parkinson JE; Smith GL
    Virology; 1994 Oct; 204(1):376-90. PubMed ID: 8091668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M; Smith GL
    Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody neutralization of the extracellular enveloped form of vaccinia virus.
    Law M; Smith GL
    Virology; 2001 Feb; 280(1):132-42. PubMed ID: 11162827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a vaccinia virus penetration protein.
    Ichihashi Y; Takahashi T; Oie M
    Virology; 1994 Aug; 202(2):834-43. PubMed ID: 8030246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
    Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus.
    Law M; Smith GL
    Methods Mol Biol; 2004; 269():187-204. PubMed ID: 15114017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
    Viner KM; Isaacs SN
    Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():2041-8. PubMed ID: 9267005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
    Lustig S; Fogg C; Whitbeck JC; Moss B
    Virology; 2004 Oct; 328(1):30-5. PubMed ID: 15380355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
    Vanderplasschen A; Hollinshead M; Smith GL
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():877-87. PubMed ID: 9568984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular enveloped vaccinia virus. Entry, egress, and evasion.
    Smith GL; Vanderplasschen A
    Adv Exp Med Biol; 1998; 440():395-414. PubMed ID: 9782308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing epitope on penetration protein of vaccinia virus.
    Ichihashi Y; Oie M
    Virology; 1996 Jun; 220(2):491-4. PubMed ID: 8661400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exit of vaccinia virus from infected cells.
    Smith GL; Law M
    Virus Res; 2004 Dec; 106(2):189-97. PubMed ID: 15567497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and immunological characterization of a recombinant secreted form of the membrane protein encoded by the vaccinia virus L1R gene.
    Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Pannell LK; Lebowitz J; Fogg C; White CL; Moss B; Cohen GH; Eisenberg RJ
    Virology; 2005 Oct; 341(1):59-71. PubMed ID: 16083934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particles.
    Husain M; Moss B
    J Virol; 2005 Apr; 79(7):4080-9. PubMed ID: 15767409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of B5R mutants of rabbitpox virus in vivo is related to impaired growth and not an enhanced host inflammatory response.
    Stern RJ; Thompson JP; Moyer RW
    Virology; 1997 Jun; 233(1):118-29. PubMed ID: 9201221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread.
    Law M; Hollinshead R; Smith GL
    J Gen Virol; 2002 Jan; 83(Pt 1):209-222. PubMed ID: 11752718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.